Minimal Residual Disease in Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Minimal Residual Disease in Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT [Phase 2, Phase 3]
Phase 2/3 trial evaluating MRD-directed donor lymphocyte infusion to reduce relapse after allogeneic hematopoietic stem cell transplantation…